Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
Contextual Use of a Healthcare Product Name
-
Regarding Section 1.5 of the PAAB Code – Materials Not Subject to Preclearance, Section D provides examples (i to v) of contextual use of a healthcare product name. Is this an exhaustive list? If we were to have a different example (not represented on the list) where the healthcare product name was used in a context not linked to therapeutic or promotional messages, could it also be considered not subject to preclearance?
-
The types of messages listed in section D are exhaustive. However, it is not exhaustive of how the principles might be demonstrated in a specific APS. We offer our opinion services if a company is unsure if an APS meets exemption criteria.
Please reach our to our admin team at review@paab.ca should you require assistance with this service.
